English Version
Each year in the United States, breast cancer is diagnosed in more than 170,000 women. Despite this substantial burden of disease, however, assessment of breast cancer risk has received very little attention outside the oncology clinic. In primary care, the main result of the recognition of individual variation in breast cancer risk is the use of age to determine recommendations regarding mammography (older age is a strong risk factor for breast cancer).
Recent developments in the ability to predict and alter breast cancer risk warrant a new look at the role of assessment of this risk in primary care. Physicians must become adept at evaluating breast cancer risk and counseling women about its effect on medical decisions. To provide both the rationale and the tools for evaluating breast cancer risk, this article examines the effects of breast cancer risk on medical decisions and explains current methods of assessing risk.
WHY EVALUATE BREAST CANCER RISK?
Several important medical decisions may be affected by a woman’s underlying risk of breast cancer. These decisions include whether to use postmenopausal hormone replacement therapy, at what age to begin mammographic screening, whether to use tamoxifen to prevent breast cancer, and whether to perform prophylactic mastectomy to prevent breast cancer.
Journals for full download on the link below
WHY EVALUATE BREAST CANCER RISK?
Several important medical decisions may be affected by a woman’s underlying risk of breast cancer. These decisions include whether to use postmenopausal hormone replacement therapy, at what age to begin mammographic screening, whether to use tamoxifen to prevent breast cancer, and whether to perform prophylactic mastectomy to prevent breast cancer.
Journals for full download on the link below
RSS Feed 
Tidak ada komentar:
Posting Komentar